24 October 2020 : Clinical Research
Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant K. pneumoniae: A Retrospective Study
Gefei He1DEFG, Juanjuan Huang1DEF, Shiqiong Huang1B, Ji Sun1C, Yulv Zhou2B, Hong Tan3B, Hui Shen4C, Zhuan Li1AG*, Jiyang Liu1AGDOI: 10.12659/MSM.925693
Med Sci Monit 2020; 26:e925693
Table 2 Drug sensitivity of CRKP strains.
| Antimicrobial agent | Number of resistant strains | Drug resistance rate (%) |
|---|---|---|
| Ampicillin | 97 | 100.00 |
| Ampicillin/sulbactam | 97 | 100.00 |
| Piperacillin/sulbactam | 97 | 100.00 |
| Cefazolin | 97 | 100.00 |
| Ceftazidime pentahydrate | 97 | 100.00 |
| Ceftriaxone sodium | 97 | 100.00 |
| Cefepime | 97 | 100.00 |
| Cefotetan | 97 | 100.00 |
| Aztreonam | 97 | 100.00 |
| Imipenem | 97 | 100.00 |
| Ertapenem | 97 | 100.00 |
| Amikacin | 47 | 48.45 |
| Gentamicin | 58 | 59.79 |
| Tobramycin | 62 | 63.92 |
| Levofloxacin tablets | 92 | 94.85 |
| Ciprofloxacin | 92 | 94.85 |
| Furadantin | 97 | 100.00 |
| Compound sulfamethoxazole | 21 | 21.65 |